Found 8 matching trials
Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis PHASE3 The purpose of this study is to gather information about the effectiveness ...
Show More Location
California Pacific Medical Center (CPMC) Research Institute
Learn More & Join Trial
Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) PHASE3 Cystinosis is an inherited disease that if untreated, results in kidney fai...
Show More Location
California Pacific Medical Center (CPMC) Research Institute
Learn More & Join Trial
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease PHASE2 A long-term extension study to assess the safety, tolerability and efficacy...
Show More Location
University of California at San Diego (UCSD)
Learn More & Join Trial
Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis PHASE3 This was a long-term, open-label study of the safety, tolerability and effe...
Show More Location
Ann & Robert H. Lurie Children's Hospital of Chicago
Learn More & Join Trial
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children PHASE2 CyNCh is a multi-center, placebo-controlled clinical trial of children ages...
Show More Location
University of California, San Diego
Learn More & Join Trial
Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis PHASE3 Cystinosis is an inherited disease that if untreated, results in kidney fai...
Show More Location
Stanford University Medical School
Learn More & Join Trial
Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease PHASE2 To evaluate safety, tolerability and efficacy of cysteamine bitartrate dela...
Show More Location
University of California at San Diego (UCSD)
Learn More & Join Trial
Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis PHASE1 Cystinosis is an inheritable disease that if untreated, results in kidney f...
Show More Location
University of California San Diego Medical Center
Learn More & Join Trial